OMER Icon

$OMER

$OMER

Omeros

Omeros is a biopharmaceutical company developing therapies including complement system inhibitors for disorders such as HSCT-associated TMA.

Stocks

Total Asset Value

$< 0.001

Holders

0

Monthly Transfer Volume

$0.00

Omeros Metrics

Tokenized Public Stocks

10 Total